Cardiovascular Safety in Drug Development and Therapeutic Use : New Methodologies and Evolving Regulatory Landscapes
Language: English
Published by Springer, 2016
- Hardcover
- Used
Seller: Buchpark, Trebbin, GermanyBuchpark
AbeBooks seller since September 30, 2021
Condition: Used - Fine
£ 71.94
Quantity: 1 available
Add to basketItem description from seller
Zustand: Sehr gut | Seiten: 368 | Sprache: Englisch | Produktart: Bücher | At a time when the field of cardiac safety is going through important changes, this unique book provides the rationale for, and cutting-edge explanations of, new regulatory landscapes that will likely govern cardiac safety assessments globally for the foreseeable future. Exposure-response modeling is already being accepted by regulatory agencies in lieu of the traditional Thorough QT/QTc Study, and the Comprehensive in vitro Proarrhythmia Assay initiative is well under way.Developments in the field of cardiovascular safety are also described and discussed in the book. These include the search for more efficient ways to exonerate new drugs for type 2 diabetes from an unacceptable cardiovascular liability, how best to address off-target blood pressure increases induced by noncardiovascular drugs, and the continued evolution of the discipline of Cardio-oncology.¿a resource that will likely serve as a standard for years to come¿ - Dr Jonathan SeltzerTherapeutic Innovation & Regulatory Science, 2017;51(2):180¿I have no hesitation in recommending this book as a valuable reference source¿ - Dr Rashmi ShahJournal for Clinical Studies, 2017;9(1):62-63.…
Seller Inventory # 26784557/12
- Title
- Cardiovascular Safety in Drug Development and Therapeutic Use : New Methodologies and Evolving Regulatory Landscapes
- Author
- Karnad, Dilip R.
- Publisher
- Springer
- Publication year
- 2016
- Condition
- Sehr gut
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 3319403451
- ISBN 13
- 9783319403458
- Seller catalogs
- Bücher
At a time when the field of cardiac safety is going through important changes, this unique book provides the rationale for, and cutting-edge explanations of, new regulatory landscapes that will likely govern cardiac safety assessments globally for the foreseeable future. Exposure-response modeling is already being accepted by regulatory agencies in lieu of the traditional Thorough QT/QTc Study, and the Comprehensive in vitro Proarrhythmia Assay initiative is well under way.
Developments in the field of cardiovascular safety are also described and discussed in the book. These include the search for more efficient ways to exonerate new drugs for type 2 diabetes from an unacceptable cardiovascular liability, how best to address off-target blood pressure increases induced by noncardiovascular drugs, and the continued evolution of the discipline of Cardio-oncology.
“a resource that will likely serve as a standard for years to come”
- Dr Jonathan Seltzer
Therapeutic Innovation & Regulatory Science, 2017;51(2):180
“I have no hesitation in recommending this book as a valuable reference source”
- Dr Rashmi Shah
Journal for Clinical Studies, 2017;9(1):62-63
"Synopsis" may belong to another edition of this title.
About the Author
J. Rick Turner, BSc (Hons), PGCE, PhD, DSc, is an experimental research scientist, clinical trialist, author, editor, and educator. He spent the first part of his professional career in the field of Cardiovascular Behavioral Medicine, detailing the individual differences apparent in cardiovascular responses to behavioral and psychological stressors, including genetic influences upon them. He received two international awards for his research, and is Co-Editor of the 2013 Springer volume Encyclopedia of Behavioral Medicine, the definitive work in this area.
Dr Turner is currently Chief Scientific Advisor, Cardiac Safety Services, and Senior Scientific Director, Clinical Communications, Quintiles. He is also member of Quintiles’ Cardiovascular and Diabetes Centers of Excellence. He is the author and co-author of over 120 publications in peer-reviewed journals, and the author, co-author,and editor of 15 books. Additionally, he holds the positions of Adjunct Professor of Pharmacy Practice, Campbell University College of Pharmacy & Health Sciences, and President and Chief Scientific Officer, Turner Medical Communications.
Dilip R. Karnad, MD, FACP, FRCP (Glasg), is an internist and an expert in cardiac safety with extensive clinical, research and teaching experience. He is currently Head of the Research Team, Cardiac Safety Services, Quintiles. He has a particular interest in statistical approaches to cardiac safety assessments, and has published over 20 papers in this field. He is a Fellow of the American College of Physicians and a Fellow of the Royal College of Physicians (of Glasgow), and also a practicing internist and critical care physician affiliated to Jupiter Hospital, Thane.
Snehal Kothari, MD, DM, FACC, FESC is a cardiologist and an expert in cardiac safety with extensive clinical, research and teaching experience. He is currently Chief Medical & Scientific Officer of the Core ECG Laboratory, Cardiac Safety Services, and Global Head of the Cardiac Safety Centre of Excellence, Quintiles. He is also a practicing Interventional Cardiologist affiliated to Lilavati Hospital & Research Centre, Mumbai. He is the recipient of over 30 awards and honors, and is a Fellow of the American College of Cardiology, the European Society of Cardiology, and the Asian Pacific Society of Cardiology. He has over 80 peer-reviewed publications and published abstracts.
"About the title" may belong to another edition of this title.
Shipping rates from Germany to U.S.A.
| Item | 60 to 60 business days | 60 to 60 business days |
|---|---|---|
| First item | £ 90.04 | £ 111.48 |
Payment methods
- Bank Wire Transfer
- Check
- Paypal
Store description
Seit über 30 Jahren handeln wir mit Büchern. Begonnen hat alles als kleiner Fachbuchhandel in Berlin. Heute sind wir spezialisiert auf den An- und Verkauf gebrauchter Bücher. Noch immer liegt unser Fokus dabei auf den Kategorien: Fachbuch und englischsprachige Literatur. Hinzu kommen Bücher aus allen anderen Genres, wie Belletristik, Biografien oder Kinderbücher. Unser oberstes Ziel ist dabei die Weiterverwendung von Dingen und die Schonung von Ressourcen. Neben dem Ankauf von privaten Büchern oder Haushaltsauflösungen kaufen wir bundesweit komplette Bibliotheken und Buchbestände von Institutionen auf, um diese nachhaltig ein weiteres Mal auf den Markt zu bringen. Parallel dazu bietet Buchpark die Möglichkeit, große Mengen einzulagern. Ganze Bibliotheken und umfangreiche Buchbestände werden von uns professionell auf Qualitätsmerkmale hin untersucht und sorgfältig für den Onlinehandel aufbereitet. Wir schenken Büchern ein zweites Leben.…
Seller's business information
Buchpark GmbH
Krügerweg 1
Trebbin, Germany 14959
Terms of sale
Buchpark
Imprint
Legal provider identification:
Buchpark GmbH
represented by the managing directors Dr. Frank Jacobi, Michael Antonius Horst Jacobi
Krügerweg 1
14959 Trebbin
Germany
Phone:+49 03381 79 76 585
E-Mail: abebooks@buchpark.de
VAT ID No.: DE243674915
registered in the commercial register of the district court Potsdam
Commercial register number HRB 33655 P
Alternative dispute resolution:
The European Commission provides a platform for out-of-court online dispute resolution (ODR platform), available at
at https://ec.europa.eu/odr.
We are a member of the "FairCommerce" initiative since 04.04.2019.
You can find more information about this at www.haendlerbund.de/faircommerce.
Cancellation policy/ sample cancellation form/
General Terms and Conditions and Customer Information/ Privacy Policy
Right of withdrawal for consumers
(A consumer is any natural person who enters into a legal transaction for purposes that are predominantly neither commercial nor self-employed).
Right of withdrawal
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Buchpark, Trebbin, Germany, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
- The delivery of newspapers, journals or magazines with the exception of subscription contracts; and
- The supply of digital content which is not supplied on a tangible medium (e.g. on a CD or DVD) if you accepted when you placed your order that we could start to deliver it, and that you could not withdraw once delivery had started.